Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Core One Labs Inc. > New Appointment
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1118)
•••
Comment by Hempdocon May 30, 2020 3:33am
204 Views
Post# 31091217

RE:New Appointment

RE:New Appointment

helpline88 wrote: We welcome Mr Shacker to Core One Labs. Most of us will know very little about Mr Shacker so time will tell whether his appointment is a postive one. We wish him good luck. Mr Shacker is President of Mota Ventures and CEO of RewardStream Inc. so not sure how much time he will have for Core One.

Regarding the negative posts, give us something to cheer about and we will.  

 

Once you connect the dots as Nickel clearly did, you will see our new BOD is no more than a Trojan Horse...a bigger, more dangerous version of the old.  This newly hand-picked majority will tow the line for Brad & continue to reward failed efforts & the deceit of shareholders. He is a true anomaly of the human race...if he is human.  JMHO.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities